blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3997223

EP3997223 - COMPOSITIONS AND METHODS FOR PREPARING NUCLEIC ACID SEQUENCING LIBRARIES USING CRISPR/CAS9 IMMOBILIZED ON A SOLID SUPPORT [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  15.04.2022
Database last updated on 14.06.2024
FormerThe international publication has been made
Status updated on  22.01.2021
Formerunknown
Status updated on  29.06.2020
Most recent event   Tooltip01.04.2023New entry: Renewal fee paid 
Applicant(s)For all designated states
Illumina Cambridge Limited
19 Granta Park
Great Abington
Cambridge CB21 6DF / GB
[2022/19]
Inventor(s)01 / GORMLEY, Niall, Anthony
19 Granta Park Great Abington
Cambridge CB21 6DF / GB
 [2022/19]
Representative(s)Murgitroyd & Company
165-169 Scotland Street
Glasgow G5 8PL / GB
[N/P]
Former [2022/19]Murgitroyd & Company
Murgitroyd House
165-169 Scotland Street
Glasgow G5 8PL / GB
Application number, filing date20733788.218.06.2020
[2022/20]
WO2020EP66959
Priority number, dateUS201962873609P12.07.2019         Original published format: US 201962873609 P
[2022/19]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2021008805
Date:21.01.2021
Language:EN
[2021/03]
Type: A1 Application with search report 
No.:EP3997223
Date:18.05.2022
Language:EN
The application published by WIPO in one of the EPO official languages on 21.01.2021 takes the place of the publication of the European patent application.
[2022/20]
Search report(s)International search report - published on:EP21.01.2021
ClassificationIPC:C12N15/10, C12Q1/6869
[2022/19]
CPC:
C12N15/1096 (EP,IL,US); C12N15/1093 (KR); C12Q1/6806 (CN,KR);
C12N15/1065 (US); C12N11/14 (US); C12N15/11 (US);
C12N9/22 (US); C12N9/80 (US); C12N9/93 (US);
C12Q1/6869 (KR); C40B50/06 (CN,KR); C12N2310/20 (EP,IL,KR,US);
C12N2800/80 (US) (-)
C-Set:
C12N15/1096, C12Q2521/301, C12Q2531/113, C12Q2565/501 (EP);
C12Q1/6806, C12Q2521/327 (CN)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2022/19]
TitleGerman:ZUSAMMENSETZUNGEN UND VERFAHREN ZUR HERSTELLUNG VON NUKLEINSÄURESEQUENZIERUNGSBIBLIOTHEKEN UNTER VERWENDUNG VON AUF EINEM FESTEN TRÄGER IMMOBILISIERTEM CRISPR/CAS9[2022/19]
English:COMPOSITIONS AND METHODS FOR PREPARING NUCLEIC ACID SEQUENCING LIBRARIES USING CRISPR/CAS9 IMMOBILIZED ON A SOLID SUPPORT[2022/19]
French:COMPOSITIONS ET PROCÉDÉS DE PRÉPARATION DE BIBLIOTHÈQUES DE SÉQUENÇAGE D'ACIDE NUCLÉIQUE À L'AIDE DE CRISPR/CAS9 IMMOBILISÉ SUR UN SUPPORT SOLIDE[2022/19]
Entry into regional phase28.05.2021National basic fee paid 
28.05.2021Designation fee(s) paid 
28.05.2021Examination fee paid 
Examination procedure28.05.2021Examination requested  [2022/20]
28.05.2021Date on which the examining division has become responsible
01.09.2022Amendment by applicant (claims and/or description)
Fees paidRenewal fee
31.03.2022Renewal fee patent year 03
31.03.2023Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[AD]WO2012025250  (ILLUMINA CAMBRIDGE LTD [GB], et al) [AD] 1-51 * page 2, line 19 - page 30, line 14; figures 1-3 *;
 [A]WO2016061517  (ILLUMINA CAMBRIDGE LTD [GB], et al) [A] 1-51 * page 1, line 25 - page 43, line 28 *;
 [A]WO2016189331  (ILLUMINA CAMBRIDGE LTD [GB]) [A] 1-51 * page 1, line 18 - page 30, line 2 *;
 [A]WO2017139354  (UNIV MICHIGAN REGENTS [US]) [A] 52-77* page 20, line 5 - page 57, line 31; figures 3-5 *;
 [A]EP3207134  (ILLUMINA CAMBRIDGE LTD [US]) [A] 1-51 * paragraph [0013] - paragraph [0138] *;
 [A]WO2017151828  (UNIVERSAL SEQUENCING TECH CORP [US]) [A] 1-51 * paragraph [0003] - paragraph [0086] *;
 [A]WO2018060740  (OXFORD NANOPORE TECH LTD [GB]) [A] 1-51 * examples 3, 6-13 *;
 [A]EP3303584  (EPICENTRE TECH CORPORATION [US]) [A] 1-51 * paragraph [0011] - paragraph [0138] *;
 [XY]US2019070314  (WANG JOSEPH [US], et al) [X] 52-54,65-67 * paragraphs [0103] - [0105] * [Y] 55-64,70-75;
 [A]US2019112643  (ARAN KIANA [US], et al) [A] 52-77 * paragraphs [0004] - [0058]; figure 5; examples 1-3 *;
 [A]EP3486331  (ILLUMINA CAMBRIDGE LTD [GB]) [A] 1-51 * paragraph [0005] - paragraph [0109] *;
 [XAY]  - VIKTORIJA GLOBYTE ET AL, "/Cas9 searches for a protospacer adjacent motif by lateral diffusion", THE EMBO JOURNAL, (20181220), vol. 38, no. 4, doi:10.15252/embj.201899466, ISSN 0261-4189, XP055729787 [X] 52-54,65-67 * the whole document * [A] 1-51 [Y] 55-64,70-75

DOI:   http://dx.doi.org/10.15252/embj.201899466
 [XAY]  - SINGH DIGVIJAY ET AL, "Mechanisms of improved specificity of engineered Cas9s revealed by single-molecule FRET analysis", NAT. STRUCT. MOL. BIOL, NATURE PUBLISHING GROUP US, NEW YORK, vol. 25, no. 4, doi:10.1038/S41594-018-0051-7, ISSN 1545-9993, (20180405), pages 347 - 354, (20180405), XP036473415 [X] 52-54,65-67 * the whole document * [A] 1-51 [Y] 55-64,70-75

DOI:   http://dx.doi.org/10.1038/s41594-018-0051-7
 [Y]  - Sungchul Kim ET AL, "Selective Prespacer Processing Ensures Precise CRISPR-Cas Adaption", bioRxiv, doi:10.1101/608976, (20190415), URL: https://www.biorxiv.org/content/10.1101/608976v1.full.pdf, (20201119), XP055752226 [Y] 55-64,70-75 * the whole document *

DOI:   http://dx.doi.org/10.1101/608976
 [A]  - KUAN FENG ET AL, "Next-generation sequencing library construction on a surface", BMC GENOMICS, BIOMED CENTRAL LTD, LONDON, UK, (20180530), vol. 19, no. 1, doi:10.1186/S12864-018-4797-4, pages 1 - 6, XP021256931 [A] 1-51 * the whole document *

DOI:   http://dx.doi.org/10.1186/s12864-018-4797-4
 [A]  - HAJIAN REZA ET AL, "Detection of unamplified target genes via CRISPR-Cas9 immobilized on a graphene field-effect transistor", NATURE BIOMEDICAL ENGINEERING, NATURE PUBLISHING GROUP UK, LONDON, (20190325), vol. 3, no. 6, doi:10.1038/S41551-019-0371-X, pages 427 - 437, XP036799471 [A] 1-51 * the whole document *

DOI:   http://dx.doi.org/10.1038/s41551-019-0371-x
 [A]  - BRUCH RICHARD ET AL, "Unamplified gene sensing via Cas9 on graphene", NATURE BIOMEDICAL ENGINEERING, NATURE PUBLISHING GROUP UK, LONDON, (20190607), vol. 3, no. 6, doi:10.1038/S41551-019-0413-4, pages 419 - 420, XP036799470 [A] 52-77 * the whole document *

DOI:   http://dx.doi.org/10.1038/s41551-019-0413-4
by applicantWO8909835
 WO8912696
 WO9001069
 WO9106678
 US5130238
 US5185243
 EP0320308
 EP0336731
 US5455166
 EP0439182
 US5573907
 US5679524
 US6210891
 US6214587
 US6258568
 US6274320
 US6355431
 WO2004018497
 US2005053980
 US6890741
 US6913884
 WO2005065814
 US2005181440
 US2005191698
 US7001792
 US7057026
 WO2006064199
 US7115400
 US7211414
 US7244559
 WO2007123744
 US7315019
 US7329492
 US2008108082
 US7405281
 US2008280773
 US2009026082
 US2009127589
 US2009186349
 US7582420
 US7595883
 US7611869
 US7670810
 US2010111768
 US2010137143
 WO2010115122
 US2010282617
 US7985565
 US8003354
 WO2012025250
 US2012282617
 US2012316086
 US2013116153
 US2013116128
 US2019202856
    - BENTLEY et al., Nature, (20080000), vol. 456, pages 53 - 59
    - LIZARDI et al., Nat. Genet., (19980000), vol. 19, pages 225 - 232
    - DEAN et al., Proc. Natl. Acad. Sci. USA, (20020000), vol. 99, pages 5261 - 66
    - WALKER et al., Nucl. Acids Res., (19920000), vol. 20, pages 1691 - 96
    - LAGE et al., Genome Research, (20030000), vol. 13, pages 294 - 307
    - GROTHUES et al., Nucleic Acids Res., (19930000), vol. 21, no. 5, pages 1321 - 2
    - RONAGHI et al., Analytical Biochemistry, (19960000), vol. 242, no. 1, pages 84 - 9
    - RONAGHI, Genome Res., (20010000), vol. 11, no. 1, pages 3 - 11
    - RONAGHI et al., Science, (19980000), vol. 281, no. 5375, page 363
    - LEVENE et al., Science, (20030000), vol. 299, pages 682 - 686
    - LUNDQUIST et al., Opt. Lett., (20080000), vol. 33, pages 1026 - 1028
    - KORLACH et al., Proc. Natl. Acad. Sci. USA, (20080000), vol. 105, pages 1176 - 1181
    - DEAMER et al., Trends Biotechnol., (20000000), vol. 18, pages 147 - 151
    - DEAMER et al., Acc. Chem. Res., (20020000), vol. 35, pages 817 - 825
    - LI et al., Nat. Mater., (20030000), vol. 2, pages 611 - 615
    - SONI et al., Clin. Chem., (20070000), vol. 53, pages 1996 - 2001
    - HEALY, Nanomed., (20070000), vol. 2, pages 459 - 481
    - COCKROFT et al., J. Am. Chem. Soc., (20080000), vol. 130, pages 818 - 820
    - WU et al., Anal Chem., (20110000), vol. 4, pages 1321 - 7
    - NITIN et al., Ann Biomed Eng., (20090000), vol. 37, pages 2018 - 2027
 WO2011US57111
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.